Blog
What Are CJC-1295 + Ipamorelin? Dual-Pathway GH Research Guide
What Are CJC-1295 + Ipamorelin? A Research-Backed Guide to Dual-Pathway GH Research
Choice Peptide Labs | 14 min read | Dual-pathway mechanism | June 2026
CJC-1295 and Ipamorelin act on two completely different receptor systems to stimulate growth hormone release. One provides a sustained baseline. The other provides pulsatile peaks. Together, they approximate the body’s natural GH secretion pattern.
What Are CJC-1295 and Ipamorelin?
CJC-1295 is a synthetic GHRH analog with four amino acid substitutions that protect against enzymatic degradation. It binds GHRH receptors on somatotroph cells in the anterior pituitary.
Ipamorelin is a selective ghrelin receptor agonist — a pentapeptide that triggers sharp, pulsatile GH release without significantly affecting cortisol, prolactin, or ACTH.
The Dual-Pathway Mechanism
| Peptide | Receptor | Effect |
|---|---|---|
| CJC-1295 | GHRH receptor | Sustained GH baseline elevation (cAMP-dependent) |
| Ipamorelin | Ghrelin receptor (GHS-R1a) | Pulsatile GH peaks, selective, no cortisol elevation |
Why Pulsatile Release Matters
Growth hormone is not released at a constant rate. It’s released in sharp bursts on top of a low baseline — primarily during deep sleep and after exercise. CJC-1295 provides the baseline. Ipamorelin provides the peaks.
Why Researchers Study Them Together
1. Dose-Response Relationship
Published neuroendocrine studies show a clear, predictable dose-response with Ipamorelin. More compound = proportionally more GH.
2. No Desensitization
The GH response to Ipamorelin does not diminish with repeated dosing. Some other secretagogues show reduced effectiveness over time.
3. Selectivity
Ipamorelin does not significantly stimulate cortisol, prolactin, or ACTH. The GH-releasing effect is isolated.
CJC-1295: The GHRH Analog
- Four amino acid substitutions protect against DPP-4 degradation
- Extended half-life: hours to days vs minutes for native GHRH
- Full GHRH receptor binding affinity preserved
- Provides sustained baseline elevation
Ipamorelin: The Selective Ghrelin Mimetic
| Feature | Ipamorelin | Other Secretagogues |
|---|---|---|
| GH selectivity | High | Variable |
| Desensitization | None | Some show reduced response |
| Dose-response | Clear, linear | Variable |
| GH pattern | Pulsatile peaks | Varies |
The Combination in Context
- Two independent pathways — GHRH receptor + ghrelin receptor don’t compete
- Additive effect — combined output greater than either alone
- Natural pattern — sustained baseline + pulsatile peaks
- Complementary timing — extended baseline + sharp, time-limited peaks
Frequently Asked Questions
Why are they studied together?
Two independent receptor systems. Combined GH output > either alone. Approximates natural pulsatile pattern.
What is CJC-1295?
Synthetic GHRH analog. Four amino acid substitutions. Sustained baseline elevation.
What is Ipamorelin?
Selective ghrelin receptor agonist. Pulsatile peaks. No cortisol/prolactin/ACTH elevation.
What is pulsatile release?
GH released in sharp bursts on a low baseline — during deep sleep and exercise.
Does Ipamorelin desensitize?
No. Response maintained with repeated dosing.
What is the GHRH receptor?
On somatotroph cells in anterior pituitary. cAMP-dependent signaling for GH production.
Explore CJC-1295 + Ipamorelin from Choice Peptide Labs
10mg blend · Published COA · USA-stocked · Cold-chain shipped
Disclaimer: For educational purposes only. Research compounds not FDA-approved. All products from Choice Peptide Labs are for laboratory research use only.
